RMD
ResMed Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$227.73
−0.64%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
18.8x
EV/EBITDA
15.0x
Market Cap
$32.85B
MomentumView details →
1D Return
−0.64%
YTD Return
−5.97%
RSI (14)
51.1
ValuationView details →
P/E (Fwd)
18.8x
EV/EBITDA
15.0x
Market Cap
$32.85B
RSI (14)
51.1
MomentumView details →
1D Return
−0.64%
YTD Return
−5.97%
SummaryUpdated Jun 1, 2026
ResMed Inc. (NYSE:RMD) is a medical device company founded in 1989 and headquartered in San Diego, California. The company went public in 1995 and has evolved from a sleep apnea device manufacturer into a comprehensive digital health platform serving patients with sleep-disordered breathing and other respiratory conditions. ResMed operates globally across approximately 140 countries, developing cloud-connected medical devices and software solutions that serve both patients in their homes and healthcare providers managing out-of-hospital care.
Similar companies
Latest newsMore news →
Resmed announced that Carol Burt will become Lead Director on November 15, 2026, succeeding Ron Taylor, who will retire after the 2026 Annual Meeting of Stockholders on November 18, 2026.18d agoResMed shares fell about 6% in morning trading on Friday after the company issued a weak fiscal 2027 revenue forecast.28d agoResMed reported Q2 CY2026 revenue of $1.46 billion, up 8.6% year on year, in line with analyst estimates, and adjusted EPS of $2.95, beating consensus by 2%.29d ago